Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR

INTRODUCTION: Patients with hereditary transthyretin amyloidosis associated with polyneuropathy (ATTRv-PN) experience deterioration in health-related quality of life (HRQOL) as the disease progresses. Findings from the randomized placebo-controlled phase III NEURO-TTR study showed treatment benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarlas, Aaron, Lovley, Andrew, McCausland, Kristen, Brown, Duncan, Vera-Llonch, Montserrat, Conceição, Isabel, Karam, Chafic, Khella, Sami, Obici, Laura, Waddington-Cruz, Márcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571454/
https://www.ncbi.nlm.nih.gov/pubmed/34355354
http://dx.doi.org/10.1007/s40120-021-00268-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571454/
https://www.ncbi.nlm.nih.gov/pubmed/34355354
http://dx.doi.org/10.1007/s40120-021-00268-x

Ejemplares similares